Total, free, and protein-bound sulphur amino acids in uraemic patients

Nephrology Dialysis Transplantation

Volumn 12, Issue 11, 1997, Pages 2332-2338

  Suliman, M E ^a   Anderstam, B ^a   Lindholm, B ^a   Bergstrom J ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Continuous ambulatory peritoneal dialysis; Cysteine; Haemodialysis; Homocysteine; Sulphur amino acid; Taurine; Uraemia

Indexed keywords

AMINO ACID; CYSTATHIONINE; CYSTEINE; CYSTINE; HOMOCYSTEINE; METHIONINE; SERINE; TAURINE;

ADULT; AGED; AMINO ACID BLOOD LEVEL; ARTICLE; CARDIOVASCULAR DISEASE; CLINICAL ARTICLE; CONSERVATIVE TREATMENT; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; CONTROLLED STUDY; FEMALE; HEMODIALYSIS; HUMAN; HYPERHOMOCYSTEINEMIA; INCIDENCE; MALE; PRIORITY JOURNAL; UREMIA;

ADULT; CYSTEINE; FEMALE; HOMOCYSTEINE; HUMANS; MALE; METHIONINE; MIDDLE AGED; PROTEIN BINDING; RENAL DIALYSIS; TAURINE; UREMIA;

EID: 0030692663     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/12.11.2332     Document Type: Article

References (45)

1. Alvestrand A, Fürst P, Bergström J. Plasma and muscle free amino acids in uremia: influence of nutrition with amino acids. Clin Nephrol 1982; 18: 297-305
2. Lindholm B, Alvestrand A, FYrst P et al. Plasma and muscle free amino acids during continuous ambulatory peritoneal dialysis. Kidney Int 1989; 35: 1219-1226
3. Flügel Link RM, Jones MR, Kopple JD. Red cell and plasma amino acid concentration in renal failure. J Parenter Enter Nutr 1976; 7: 450-456
4. Wilcken DE, Gupta VJ. Sulphur containing amino acids in chronic renal failure with particular reference to homocystine and cysteine-homocysteine mixed disulphide. Eur J Clin Invest 1979; 9: 301-307
5. Wilcken DE, Gupta VJ, Reddy SG. Accumulation of sulphur-containing amino acids including cysteine-homocysteine in patients on maintenance haemodialysis. Clin Sci 1980; 58: 427-430
6. Smolin LA, Laidlaw SA, Kopple JD. Altered plasma free and protein-bound sulphur amino acids in patients undergoing maintenance hemodialysis. Am J Clin Nutr 1987; 45: 737-743
7. Suliman ME, Anderstam B, Bergström J. Evidence of taurine depletion and accumulation of cysteinesulfinic acid in chronic dialysis patients. Kidney Int 1996; 50: 1713-1717
8. Alvestrand A, Fürst P, Bergström J. Intracellular amino acids in uremia. Kidney Int 1983; 24 [Supp13]: S9-S16
9. Giordano C, De Santo N, Copodicasa G. Amino acids losses during continuous ambulatory peritoneal dialysis, Clin Nephrol 1980; 14: 230-232
10. Oren A, Wu G, Anderson GH et al. Effective use of amino acid dialysate over 4 weeks in CAPD patients. Perit Dial Bull 1983; 3: 66-73
11. Bergström J, Alvestrand A, Fürst P et al. Sulphur amino acids in plasma and muscle in patients with chronic renal failure : evidence for taurine depletion. J Intern Med 1989; 226: 189-194
12. Moise SN, Pacioretty LM, Kallfelz FA et al. Dietary taurine deficiency and dilated cardiomyopathy in the fox. Am Heart J 1996; 121: 541-547
13. Azuma J, Hasegawa H, Sawamura A. Taurine for treatment of congestive heart failure. Int J Cardiol 1982; 2: 303-309
14. Azuma J, Hasegawa H, Sawamura A. Therapy of congestive heart failure with orally administered taurine. Clin Ther 1983; 5: 398-408
15. Azuma J, Sawamura H, Awata N. Theraputic effect of taurine in congestive heart failure: a double-blind crossover trial. Clin Cardiol 1985; 8: 276-282
16. Huxtable RJ. Physiological actions of taurine. Physiol Rev 1992; 72: 101-163
17. Ueland PM, Mansoor MA, Guttormsen AB et al. Reduced, oxidized and protein-bound forms of homocysteine and other aminothiols in plasma comprise the redox thiol status - a possible element of the extracellular antioxidant defense system. J Nutr 1996; 126: 1281S-1284S
18. Ueland PM, Refsum H. Plasma homocysteine, a risk factor for vascular disease: plasma levels in health, disease, and drug therapy. J Lab Clin Med 1989; 114: 473-501
19. Chauveau P, Chadefaux B, Coude M et al. Increased plasma homocysteine concentration in patients with chronic renal failure. Miner Electrolyte Metab 1992; 18: 196-198
20. Hultberg B, Andersson A, Sterner G. Plasma homocysteine in renal failure. Clin Nephrol 1993; 40: 230-235
21. Massy ZA, Chadefaux-Vekemans B, Chevalier A et al. Hyperhomocysteinaemia: a significant risk factor for cardiovascular disease in renal transplant recipients. Nephrol Dial Transplant 1994; 9: 1103-1108
22. Janssen MJ, van den Berg M, Stehouwer CD et al. Hyperhomocysteinaemia: a role in the accelerated atherogenesis of chronic renal failure. Neth J Med 1995; 46: 244-251
23. Friedman JA, Dwyer JT. Hyperhomocysteinemia as a risk factor for cardiovascular disease in patients undergoing hemodialysis. Nutr Rev 1995; 53: 197-201
24. Bostom AG, Shemin D, Lapane KL et al. Hyperhomocysteinemia and traditional cardiovascular disease risk factors in end-stage renal disease patients on dialysis: a case-control study. Atherosclerosis 1995; 114: 93-103
25. Cohen SA, De Antonis KM. Applications of amino acid derivitization with 6-aminoquinolyl-N-hydroxysuccinimidyl carbamate: Analysis of feed grains, intravenous solutions and glycoproteins. J Chromatogr 1994; 661: 25-34
26. Refsum H, Heiland S, Ueland PM. Radioenzymic determination of homocysteine in plasma and urine, Clin Chem 1985; 31: 624-628
27. Araki A, Sako Y. Determination of free and total homocysteine in human plasma by high-performance liquid chromatography with fluorescence detection. J Chromatogr 1987; 422: 43-52
28. Gulyassy P, Aviram A, Peters J. Evaluation of protein requirements in uremia. Arch Intern Med 1970; 26: 855-859
29. Bostom AG, Shemin D, Lapane KL et al Folate status is the major determinant of fasting total plasma homocysteine levels in maintenance dialysis patients. Atherosclerosis 1996; 123: 193-202
30. Bachmann J, Tepel M, Raidt H et al. Hyperhomocysteinemia and the risk for vascular disease in hemodialysis patients. J Am Soc Nephrol 1995; 6: 121-125
31. Lindup WE, Bishop KA, Collier R. Drug binding defect of uremic plasma: contribution of endogenous binding inhibitors. In: Tillement JP, Lindenlaub E, eds. Protein Binding and Drug Transport. Schattauer, Stuttgart, 1985
32. Gulyassy PF, Bottini AT, Stanfel LA et al. Isolation and chemical identification of inhibitors of plasma ligand binding. Kidney Int 1986; 30: 391-398
33. Andersson A, Brattström L, Israelsson B et al. Plasma homocysteine before and after methionine loading with regard to age, gender, and menopausal status. Eur J Clin Invest 1992; 22: 79-87
34. Wouters MGA, Moorrees M, Van Der Mooren MJ et al. Plasma homocysteine and menopausal status. Eur J Clin Invest 1995; 25: 801-805
35. Wilcken DE, Wilcken B. The pathogenesis of coronary artery disease: a possible role for methionine metabolism. J Clin Invest 1976; 57: 1079-1082
36. Tizianello A, Deferrari G, Gariboto G et al. Renal metabolism of amino acids and ammonia in subjects with normal renal functions and patients with chronic renal insufficiency. J Clin Invest 1980; 65: 1162-1173
37. Janssen MJFM, van Guldener C, Th. de Jong GM et al. Folic acid treatment of hyperhomocysteinemia in dialysis patients. Miner Electrolyte Metab 1996; 22: 110-114
38. Chauveau P, Chadefaux B, Coude M et al. Hyperhomocysteinemia, a risk factor for atherosclerosis in chronic uremic patients. Kidney Int 1993; 43 [Supp 41]: S72-S77
39. Chauveau P, Chadefaux B, Kolko A et al. Hyperhomocysteinemia in hemodialyzed patients: effect of folate supplementation and dialysis membranes. JASN 1996; 7: 1475, Abstract A1132
40. Kang SS, Wong PWK, Bidant A et al. Plasma protein-bound homocysteine in patients requiring chronic hemodialysis. Clin Sd 1983; 65: 335-336
41. Wiley VC, Dudman NPB, Wilcken DEL. Interrelations between plasma free and protein-bound homocysteine and cysteine in homocysteinuria. Metabolism 1988; 37: 191-195
42. Qureshi GA, Qureshi AR, Bergström J. Quantitation of free amino acids in plasma and muscle samples from healthy subjects and uremic patients by high-performance liquid chromatography and fluorescence detection. J Pharm Biomed Anal 1989; 7(3): 377-384
43. Young AG, Swanepoel CR, Croft MR et al. Anthropometry and plasma valine, amino acids, and proteins in the nutritional assessment of hemodialysis patients. Kidney Int 1982; 21: 492-499
44. Trautwein EA, Hayes KC. Taurine concentration in plasma and whole blood in humans: estimation of error from intra- and interindividual variation and sampling technique. Am J Clin Nutr. 1990; 52: 758-764
45. Möller P, Bergström J, Eriksson S et al. Effect of ageing on free amino acids and electrolytes in leg skeletal muscle. Clin Sci 1979; 56: 427-432